Journal article
Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial
Abstract
OBJECTIVE: The objective was to evaluate the efficacy and safety of single-dose ketamine infusion in adults with sickle cell disease (SCD) who presented with acute sickle vasoocclusive crisis (VOC).
METHODS: This study was a parallel-group, prospective, randomized, double-blind, pragmatic trial. Participants were randomized to receive a single dose of either ketamine or morphine, infused over 30 min. Primary outcome was mean difference in the …
Authors
Alshahrani MS; AlSulaibikh AH; ElTahan MR; AlFaraj SZ; Asonto LP; AlMulhim AA; AlAbbad MF; Almaghraby N; AlJumaan MA; AlJunaid TO
Journal
Academic Emergency Medicine, Vol. 29, No. 2, pp. 150–158
Publisher
Wiley
Publication Date
February 2022
DOI
10.1111/acem.14382
ISSN
1069-6563